https://doi.org/10.4081/mm.2023.11382
Screening microbiologico esteso nel paziente ematologico con neutropenia febbrile: risultati preliminari di uno studio monocentrico
Published: 11 April 2023
Abstract Views: 524
PDF: 238
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
Not available.
Zimmer, A. J.; Freifeld, A. G. Optimal Management of Neutropenic Fever in Patients With Cancer. J Oncol Pract 2019;15:19-24.
DOI: https://doi.org/10.1200/JOP.18.00269
Nesher, L.; Rolston, K. V. The current spectrum of infection in cancer patients with chemotherapy related neutropenia. Infection 2014;42:5-13.
DOI: https://doi.org/10.1007/s15010-013-0525-9
Stern, A.; Carrara, E.; Bitterman, R.; Yahav, D.; Leibovici, L.; Paul, M. Early discontinuation of antibiotics for febrile neutropenia versus continuation until neutropenia resolution in people with cancer. Cochrane Database Syst Rev 2019;1:CD012184.
DOI: https://doi.org/10.1002/14651858.CD012184.pub2
How to Cite
Bertoldi, A., Crovara Pesce, C. M., Nigrisoli, G., Bianchini, I., Vignudelli, E., Barbiero, A., Bartoletti, M., Bussini, L., & Ambretti, S. (2023). Screening microbiologico esteso nel paziente ematologico con neutropenia febbrile: risultati preliminari di uno studio monocentrico. Microbiologia Medica, 38(1). https://doi.org/10.4081/mm.2023.11382
Copyright (c) 2023 the Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.